Intuitive Surgical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ISRG research report →
About the company
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets.
- CEO
- David J. Rosa
- IPO
- 2000
- Employees
- 15,638
- HQ
- Sunnyvale, CA, US
Price Chart
- Market Cap
- $143.04B
- P/E
- 48.11
- P/S
- 13.52
- P/B
- 8.20
- EV/EBITDA
- 32.64
- Div Yield
- 0.00%
- Gross Margin
- 66.29%
- Op Margin
- 30.45%
- Net Margin
- 28.15%
- ROE
- 17.01%
- ROIC
- 16.49%
- Revenue
- $10.06B · 20.51%
- Net Income
- $2.86B · 22.97%
- EPS
- $8.00 · 22.32%
- Op Income
- $2.95B
- FCF YoY
- 91.03%
- 52W High
- $603.88
- 52W Low
- $396.68
- 50D MA
- $440.84
- 200D MA
- $491.00
- Beta
- 1.45
- Avg Volume
- 2.21M
Get TickerSpark's AI analysis on ISRG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | Brosius Mark | sell | 23 |
| Jun 12, 26 | Brosius Mark | sell | 25 |
| Jun 8, 26 | Brosius Mark | sell | 23 |
| Jun 9, 26 | Brosius Mark | sell | 23 |
| Jun 10, 26 | Brosius Mark | sell | 23 |
| Jun 10, 26 | LOEB GARY | sell | 400 |
| Jun 10, 26 | Rosa David J. | other | 1,358 |
| Jun 10, 26 | Rosa David J. | other | 674 |
| Jun 10, 26 | Rosa David J. | other | 1,358 |
| Jun 1, 26 | Jeddi Iman | other | 5,625 |
Our ISRG coverage
Recent articles, reports, and earnings notes.
Intuitive Surgical (ISRG): Premium Growth With da Vinci 5
Intuitive Surgical is still compounding through mid-teens procedure growth, rising da Vinci 5 adoption, and a highly recurring revenue mix. The stock looks like a quality-growth name with strong execution, but valuation remains rich.
How to Invest in Figure AI in 2026: A Realistic Guide
No, Figure AI is not publicly traded. Retail investors generally can’t buy it directly unless they get access to private secondary shares as accredited investors or wait for a future IPO.
Intuitive Surgical, Inc. (ISRG) drops 6.5% on valuation
Intuitive Surgical, Inc. (ISRG) drops sharply as investors rotate out of expensive healthcare growth stocks. The company’s fundamentals remain strong after a solid Q1 2026 report, but its premium valuation and margin concerns are pressuring the shares today.
Want a deeper read on ISRG?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.